Report cover image

Global Clinical Oncology Next Generation Sequencing Databank Market Report

Publisher Magna Intelligence
Published Apr 26, 2024
Length 100 Pages
SKU # MAIN18749880

Description

Global Clinical Oncology Next Generation Sequencing Databank Market Report


The Clinical Oncology Next Generation Sequencing market was valued at $327.7 Million in 2020, and is projected to reach $644.4 Million by 2029 growing at a CAGR of 7.85% from 2021 to 2029. Data Analysis segment is expected to be the highest contributor to this market, with $163.4 Million in 2020, and is anticipated to reach $330.9 Million by 2029, registering a CAGR of 8.20%. Sequencing segment is anticipated to reach $111.5 Million by 2029 with the highest CAGR of 8.91%. Data Analysis and Pre-Sequencing segments collectively expected to account for about 84.2% share of the Clinical Oncology Next Generation Sequencing market in 2020, with the former constituting around 49.9% share. Sequencing and Data Analysis segments are expected to witness significant growth rates at a CAGR of 8.91% and 8.20% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 65.7% in the overall Clinical Oncology Next Generation Sequencing market in 2020, and is anticipated to reach 68.6% by 2029.

Table of Contents

100 Pages
1. Global Clinical Oncology Next Generation Sequencing Market, By Workflow
1.1. Overview
1.2. Sequencing
1.2.1 Sequencing Market, By Region
1.2.1.1 North America Sequencing Market, By Country
1.2.1.2 Europe Sequencing Market, By Country
1.2.1.3 Asia-Pacific Sequencing Market, By Country
1.2.1.4 Rest of World Sequencing Market, By Country
1.3. Pre-Sequencing
1.3.1 Pre-Sequencing Market, By Region
1.3.1.1 North America Pre-Sequencing Market, By Country
1.3.1.2 Europe Pre-Sequencing Market, By Country
1.3.1.3 Asia-Pacific Pre-Sequencing Market, By Country
1.3.1.4 Rest of World Pre-Sequencing Market, By Country
1.4. Data Analysis
1.4.1 Data Analysis Market, By Region
1.4.1.1 North America Data Analysis Market, By Country
1.4.1.2 Europe Data Analysis Market, By Country
1.4.1.3 Asia-Pacific Data Analysis Market, By Country
1.4.1.4 Rest of World Data Analysis Market, By Country
2. Global Clinical Oncology Next Generation Sequencing Market, By Technology
2.1. Overview
2.2. Whole Exome Sequencing
2.2.1 Whole Exome Sequencing Market, By Region
2.2.1.1 North America Whole Exome Sequencing Market, By Country
2.2.1.2 Europe Whole Exome Sequencing Market, By Country
2.2.1.3 Asia-Pacific Whole Exome Sequencing Market, By Country
2.2.1.4 Rest of World Whole Exome Sequencing Market, By Country
2.3. Whole Genome Sequencing
2.3.1 Whole Genome Sequencing Market, By Region
2.3.1.1 North America Whole Genome Sequencing Market, By Country
2.3.1.2 Europe Whole Genome Sequencing Market, By Country
2.3.1.3 Asia-Pacific Whole Genome Sequencing Market, By Country
2.3.1.4 Rest of World Whole Genome Sequencing Market, By Country
2.4. Targeted Sequencing & Resequencing Centrifuges
2.4.1 Targeted Sequencing & Resequencing Centrifuges Market, By Region
2.4.1.1 North America Targeted Sequencing & Resequencing Centrifuges Market, By Country
2.4.1.2 Europe Targeted Sequencing & Resequencing Centrifuges Market, By Country
2.4.1.3 Asia-Pacific Targeted Sequencing & Resequencing Centrifuges Market, By Country
2.4.1.4 Rest of World Targeted Sequencing & Resequencing Centrifuges Market, By Country
3. Global Clinical Oncology Next Generation Sequencing Market, By Application
3.1. Overview
3.2. Companion Diagnostics
3.2.1 Companion Diagnostics Market, By Region
3.2.1.1 North America Companion Diagnostics Market, By Country
3.2.1.2 Europe Companion Diagnostics Market, By Country
3.2.1.3 Asia-Pacific Companion Diagnostics Market, By Country
3.2.1.4 Rest of World Companion Diagnostics Market, By Country
3.3. Screening
3.3.1 Screening Market, By Region
3.3.1.1 North America Screening Market, By Country
3.3.1.2 Europe Screening Market, By Country
3.3.1.3 Asia-Pacific Screening Market, By Country
3.3.1.4 Rest of World Screening Market, By Country
3.4. Other Applications
3.4.1 Other Applications Market, By Region
3.4.1.1 North America Other Applications Market, By Country
3.4.1.2 Europe Other Applications Market, By Country
3.4.1.3 Asia-Pacific Other Applications Market, By Country
3.4.1.4 Rest of World Other Applications Market, By Country
4. Global Clinical Oncology Next Generation Sequencing Market, By End User
4.1. Overview
4.2. Clinics
4.2.1 Clinics Market, By Region
4.2.1.1 North America Clinics Market, By Country
4.2.1.2 Europe Clinics Market, By Country
4.2.1.3 Asia-Pacific Clinics Market, By Country
4.2.1.4 Rest of World Clinics Market, By Country
4.3. Hospitals
4.3.1 Hospitals Market, By Region
4.3.1.1 North America Hospitals Market, By Country
4.3.1.2 Europe Hospitals Market, By Country
4.3.1.3 Asia-Pacific Hospitals Market, By Country
4.3.1.4 Rest of World Hospitals Market, By Country
4.4. Laboratories
4.4.1 Laboratories Market, By Region
4.4.1.1 North America Laboratories Market, By Country
4.4.1.2 Europe Laboratories Market, By Country
4.4.1.3 Asia-Pacific Laboratories Market, By Country
4.4.1.4 Rest of World Laboratories Market, By Country
5. Global Clinical Oncology Next Generation Sequencing Market, By Region
5.1. Overview
5.2. North America
5.2.1 North America Clinical Oncology Next Generation Sequencing Market, By Workflow
5.2.2 North America Clinical Oncology Next Generation Sequencing Market, By Technology
5.2.3 North America Clinical Oncology Next Generation Sequencing Market, By Application
5.2.4 North America Clinical Oncology Next Generation Sequencing Market, By End User
5.2.5 North America Clinical Oncology Next Generation Sequencing Market, By Country
5.2.5.1 U.S.
5.2.5.1.1 U.S. Clinical Oncology Next Generation Sequencing Market, By Workflow
5.2.5.1.2 U.S. Clinical Oncology Next Generation Sequencing Market, By Technology
5.2.5.1.3 U.S. Clinical Oncology Next Generation Sequencing Market, By Application
5.2.5.1.4 U.S. Clinical Oncology Next Generation Sequencing Market, By End User
5.2.5.2 Canada
5.2.5.2.1 Canada Clinical Oncology Next Generation Sequencing Market, By Workflow
5.2.5.2.2 Canada Clinical Oncology Next Generation Sequencing Market, By Technology
5.2.5.2.3 Canada Clinical Oncology Next Generation Sequencing Market, By Application
5.2.5.2.4 Canada Clinical Oncology Next Generation Sequencing Market, By End User
5.2.5.3 Mexico
5.2.5.3.1 Mexico Clinical Oncology Next Generation Sequencing Market, By Workflow
5.2.5.3.2 Mexico Clinical Oncology Next Generation Sequencing Market, By Technology
5.2.5.3.3 Mexico Clinical Oncology Next Generation Sequencing Market, By Application
5.2.5.3.4 Mexico Clinical Oncology Next Generation Sequencing Market, By End User
5.3. Europe
5.3.1 Europe Clinical Oncology Next Generation Sequencing Market, By Workflow
5.3.2 Europe Clinical Oncology Next Generation Sequencing Market, By Technology
5.3.3 Europe Clinical Oncology Next Generation Sequencing Market, By Application
5.3.4 Europe Clinical Oncology Next Generation Sequencing Market, By End User
5.3.5 Europe Clinical Oncology Next Generation Sequencing Market, By Country
5.3.5.1 Germany
5.3.5.1.1 Germany Clinical Oncology Next Generation Sequencing Market, By Workflow
5.3.5.1.2 Germany Clinical Oncology Next Generation Sequencing Market, By Technology
5.3.5.1.3 Germany Clinical Oncology Next Generation Sequencing Market, By Application
5.3.5.1.4 Germany Clinical Oncology Next Generation Sequencing Market, By End User
5.3.5.2 France
5.3.5.2.1 France Clinical Oncology Next Generation Sequencing Market, By Workflow
5.3.5.2.2 France Clinical Oncology Next Generation Sequencing Market, By Technology
5.3.5.2.3 France Clinical Oncology Next Generation Sequencing Market, By Application
5.3.5.2.4 France Clinical Oncology Next Generation Sequencing Market, By End User
5.3.5.3 U.K.
5.3.5.3.1 U.K. Clinical Oncology Next Generation Sequencing Market, By Workflow
5.3.5.3.2 U.K. Clinical Oncology Next Generation Sequencing Market, By Technology
5.3.5.3.3 U.K. Clinical Oncology Next Generation Sequencing Market, By Application
5.3.5.3.4 U.K. Clinical Oncology Next Generation Sequencing Market, By End User
5.3.5.4 Italy
5.3.5.4.1 Italy Clinical Oncology Next Generation Sequencing Market, By Workflow
5.3.5.4.2 Italy Clinical Oncology Next Generation Sequencing Market, By Technology
5.3.5.4.3 Italy Clinical Oncology Next Generation Sequencing Market, By Application
5.3.5.4.4 Italy Clinical Oncology Next Generation Sequencing Market, By End User
5.3.5.5 Spain
5.3.5.5.1 Spain Clinical Oncology Next Generation Sequencing Market, By Workflow
5.3.5.5.2 Spain Clinical Oncology Next Generation Sequencing Market, By Technology
5.3.5.5.3 Spain Clinical Oncology Next Generation Sequencing Market, By Application
5.3.5.5.4 Spain Clinical Oncology Next Generation Sequencing Market, By End User
5.3.5.6 Rest of Europe
5.3.5.6.1 Rest of Europe Clinical Oncology Next Generation Sequencing Market, By Workflow
5.3.5.6.2 Rest of Europe Clinical Oncology Next Generation Sequencing Market, By Technology
5.3.5.6.3 Rest of Europe Clinical Oncology Next Generation Sequencing Market, By Application
5.3.5.6.4 Rest of Europe Clinical Oncology Next Generation Sequencing Market, By End User
5.4. Asia-Pacific
5.4.1 Asia-Pacific Clinical Oncology Next Generation Sequencing Market, By Workflow
5.4.2 Asia-Pacific Clinical Oncology Next Generation Sequencing Market, By Technology
5.4.3 Asia-Pacific Clinical Oncology Next Generation Sequencing Market, By Application
5.4.4 Asia-Pacific Clinical Oncology Next Generation Sequencing Market, By End User
5.4.5 Asia-Pacific Clinical Oncology Next Generation Sequencing Market, By Country
5.4.5.1 China
5.4.5.1.1 China Clinical Oncology Next Generation Sequencing Market, By Workflow
5.4.5.1.2 China Clinical Oncology Next Generation Sequencing Market, By Technology
5.4.5.1.3 China Clinical Oncology Next Generation Sequencing Market, By Application
5.4.5.1.4 China Clinical Oncology Next Generation Sequencing Market, By End User
5.4.5.2 India
5.4.5.2.1 India Clinical Oncology Next Generation Sequencing Market, By Workflow
5.4.5.2.2 India Clinical Oncology Next Generation Sequencing Market, By Technology
5.4.5.2.3 India Clinical Oncology Next Generation Sequencing Market, By Application
5.4.5.2.4 India Clinical Oncology Next Generation Sequencing Market, By End User
5.4.5.3 Japan
5.4.5.3.1 Japan Clinical Oncology Next Generation Sequencing Market, By Workflow
5.4.5.3.2 Japan Clinical Oncology Next Generation Sequencing Market, By Technology
5.4.5.3.3 Japan Clinical Oncology Next Generation Sequencing Market, By Application
5.4.5.3.4 Japan Clinical Oncology Next Generation Sequencing Market, By End User
5.4.5.4 Australia
5.4.5.4.1 Australia Clinical Oncology Next Generation Sequencing Market, By Workflow
5.4.5.4.2 Australia Clinical Oncology Next Generation Sequencing Market, By Technology
5.4.5.4.3 Australia Clinical Oncology Next Generation Sequencing Market, By Application
5.4.5.4.4 Australia Clinical Oncology Next Generation Sequencing Market, By End User
5.4.5.5 South Korea
5.4.5.5.1 South Korea Clinical Oncology Next Generation Sequencing Market, By Workflow
5.4.5.5.2 South Korea Clinical Oncology Next Generation Sequencing Market, By Technology
5.4.5.5.3 South Korea Clinical Oncology Next Generation Sequencing Market, By Application
5.4.5.5.4 South Korea Clinical Oncology Next Generation Sequencing Market, By End User
5.4.5.6 Rest of Asia
5.4.5.6.1 Rest of Asia Clinical Oncology Next Generation Sequencing Market, By Workflow
5.4.5.6.2 Rest of Asia Clinical Oncology Next Generation Sequencing Market, By Technology
5.4.5.6.3 Rest of Asia Clinical Oncology Next Generation Sequencing Market, By Application
5.4.5.6.4 Rest of Asia Clinical Oncology Next Generation Sequencing Market, By End User
5.5. Rest of World
5.5.1 Rest of World Clinical Oncology Next Generation Sequencing Market, By Workflow
5.5.2 Rest of World Clinical Oncology Next Generation Sequencing Market, By Technology
5.5.3 Rest of World Clinical Oncology Next Generation Sequencing Market, By Application
5.5.4 Rest of World Clinical Oncology Next Generation Sequencing Market, By End User
5.5.5 Rest of World Clinical Oncology Next Generation Sequencing Market, By Country
5.5.5.1 Brazil
5.5.5.1.1 Brazil Clinical Oncology Next Generation Sequencing Market, By Workflow
5.5.5.1.2 Brazil Clinical Oncology Next Generation Sequencing Market, By Technology
5.5.5.1.3 Brazil Clinical Oncology Next Generation Sequencing Market, By Application
5.5.5.1.4 Brazil Clinical Oncology Next Generation Sequencing Market, By End User
5.5.5.2 South Africa
5.5.5.2.1 South Africa Clinical Oncology Next Generation Sequencing Market, By Workflow
5.5.5.2.2 South Africa Clinical Oncology Next Generation Sequencing Market, By Technology
5.5.5.2.3 South Africa Clinical Oncology Next Generation Sequencing Market, By Application
5.5.5.2.4 South Africa Clinical Oncology Next Generation Sequencing Market, By End User
5.5.5.3 GCC
5.5.5.3.1 GCC Clinical Oncology Next Generation Sequencing Market, By Workflow
5.5.5.3.2 GCC Clinical Oncology Next Generation Sequencing Market, By Technology
5.5.5.3.3 GCC Clinical Oncology Next Generation Sequencing Market, By Application
5.5.5.3.4 GCC Clinical Oncology Next Generation Sequencing Market, By End User
5.5.5.4 RoW Countries
5.5.5.4.1 RoW Countries Clinical Oncology Next Generation Sequencing Market, By Workflow
5.5.5.4.2 RoW Countries Clinical Oncology Next Generation Sequencing Market, By Technology
5.5.5.4.3 RoW Countries Clinical Oncology Next Generation Sequencing Market, By Application
5.5.5.4.4 RoW Countries Clinical Oncology Next Generation Sequencing Market, By End User
RoW Countries Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD LIST OF TABLES
TABLE 1. Global Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 2. Sequencing Market Value, By Region, 2020-2029, Million USD
TABLE 3. North America Sequencing Market Value, By Country, 2020-2029, Million USD
TABLE 4. Europe Sequencing Market Value, By Country, 2020-2029, Million USD
TABLE 5. Asia-Pacific Sequencing Market Value, By Country, 2020-2029, Million USD
TABLE 6. Rest of World Sequencing Market Value, By Country, 2020-2029, Million USD
TABLE 7. Pre-Sequencing Market Value, By Region, 2020-2029, Million USD
TABLE 8. North America Pre-Sequencing Market Value, By Country, 2020-2029, Million USD
TABLE 9. Europe Pre-Sequencing Market Value, By Country, 2020-2029, Million USD
TABLE 10. Asia-Pacific Pre-Sequencing Market Value, By Country, 2020-2029, Million USD
TABLE 11. Rest of World Pre-Sequencing Market Value, By Country, 2020-2029, Million USD
TABLE 12. Data Analysis Market Value, By Region, 2020-2029, Million USD
TABLE 13. North America Data Analysis Market Value, By Country, 2020-2029, Million USD
TABLE 14. Europe Data Analysis Market Value, By Country, 2020-2029, Million USD
TABLE 15. Asia-Pacific Data Analysis Market Value, By Country, 2020-2029, Million USD
TABLE 16. Rest of World Data Analysis Market Value, By Country, 2020-2029, Million USD
TABLE 17. Global Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 18. Whole Exome Sequencing Market Value, By Region, 2020-2029, Million USD
TABLE 19. North America Whole Exome Sequencing Market Value, By Country, 2020-2029, Million USD
TABLE 20. Europe Whole Exome Sequencing Market Value, By Country, 2020-2029, Million USD
TABLE 21. Asia-Pacific Whole Exome Sequencing Market Value, By Country, 2020-2029, Million USD
TABLE 22. Rest of World Whole Exome Sequencing Market Value, By Country, 2020-2029, Million USD
TABLE 23. Whole Genome Sequencing Market Value, By Region, 2020-2029, Million USD
TABLE 24. North America Whole Genome Sequencing Market Value, By Country, 2020-2029, Million USD
TABLE 25. Europe Whole Genome Sequencing Market Value, By Country, 2020-2029, Million USD
TABLE 26. Asia-Pacific Whole Genome Sequencing Market Value, By Country, 2020-2029, Million USD
TABLE 27. Rest of World Whole Genome Sequencing Market Value, By Country, 2020-2029, Million USD
TABLE 28. Targeted Sequencing & Resequencing Centrifuges Market Value, By Region, 2020-2029, Million USD
TABLE 29. North America Targeted Sequencing & Resequencing Centrifuges Market Value, By Country, 2020-2029, Million USD
TABLE 30. Europe Targeted Sequencing & Resequencing Centrifuges Market Value, By Country, 2020-2029, Million USD
TABLE 31. Asia-Pacific Targeted Sequencing & Resequencing Centrifuges Market Value, By Country, 2020-2029, Million USD
TABLE 32. Rest of World Targeted Sequencing & Resequencing Centrifuges Market Value, By Country, 2020-2029, Million USD
TABLE 33. Global Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 34. Companion Diagnostics Market Value, By Region, 2020-2029, Million USD
TABLE 35. North America Companion Diagnostics Market Value, By Country, 2020-2029, Million USD
TABLE 36. Europe Companion Diagnostics Market Value, By Country, 2020-2029, Million USD
TABLE 37. Asia-Pacific Companion Diagnostics Market Value, By Country, 2020-2029, Million USD
TABLE 38. Rest of World Companion Diagnostics Market Value, By Country, 2020-2029, Million USD
TABLE 39. Screening Market Value, By Region, 2020-2029, Million USD
TABLE 40. North America Screening Market Value, By Country, 2020-2029, Million USD
TABLE 41. Europe Screening Market Value, By Country, 2020-2029, Million USD
TABLE 42. Asia-Pacific Screening Market Value, By Country, 2020-2029, Million USD
TABLE 43. Rest of World Screening Market Value, By Country, 2020-2029, Million USD
TABLE 44. Other Applications Market Value, By Region, 2020-2029, Million USD
TABLE 45. North America Other Applications Market Value, By Country, 2020-2029, Million USD
TABLE 46. Europe Other Applications Market Value, By Country, 2020-2029, Million USD
TABLE 47. Asia-Pacific Other Applications Market Value, By Country, 2020-2029, Million USD
TABLE 48. Rest of World Other Applications Market Value, By Country, 2020-2029, Million USD
TABLE 49. Global Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 50. Clinics Market Value, By Region, 2020-2029, Million USD
TABLE 51. North America Clinics Market Value, By Country, 2020-2029, Million USD
TABLE 52. Europe Clinics Market Value, By Country, 2020-2029, Million USD
TABLE 53. Asia-Pacific Clinics Market Value, By Country, 2020-2029, Million USD
TABLE 54. Rest of World Clinics Market Value, By Country, 2020-2029, Million USD
TABLE 55. Hospitals Market Value, By Region, 2020-2029, Million USD
TABLE 56. North America Hospitals Market Value, By Country, 2020-2029, Million USD
TABLE 57. Europe Hospitals Market Value, By Country, 2020-2029, Million USD
TABLE 58. Asia-Pacific Hospitals Market Value, By Country, 2020-2029, Million USD
TABLE 59. Rest of World Hospitals Market Value, By Country, 2020-2029, Million USD
TABLE 60. Laboratories Market Value, By Region, 2020-2029, Million USD
TABLE 61. North America Laboratories Market Value, By Country, 2020-2029, Million USD
TABLE 62. Europe Laboratories Market Value, By Country, 2020-2029, Million USD
TABLE 63. Asia-Pacific Laboratories Market Value, By Country, 2020-2029, Million USD
TABLE 64. Rest of World Laboratories Market Value, By Country, 2020-2029, Million USD
TABLE 65. Global Clinical Oncology Next Generation Sequencing Market Value, By Region, 2020-2029, Million USD
TABLE 66. North America Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 67. North America Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 68. North America Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 69. North America Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 70. North America Clinical Oncology Next Generation Sequencing Market Value, By Country, 2020-2029, Million USD
TABLE 71. U.S. Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 72. U.S. Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 73. U.S. Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 74. U.S. Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 75. Canada Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 76. Canada Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 77. Canada Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 78. Canada Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 79. Mexico Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 80. Mexico Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 81. Mexico Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 82. Mexico Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 83. Europe Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 84. Europe Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 85. Europe Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 86. Europe Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 87. Europe Clinical Oncology Next Generation Sequencing Market Value, By Country, 2020-2029, Million USD
TABLE 88. Germany Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 89. Germany Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 90. Germany Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 91. Germany Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 92. France Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 93. France Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 94. France Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 95. France Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 96. U.K. Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 97. U.K. Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 98. U.K. Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 99. U.K. Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 100. Italy Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 101. Italy Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 102. Italy Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 103. Italy Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 104. Spain Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 105. Spain Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 106. Spain Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 107. Spain Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 108. Rest of Europe Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 109. Rest of Europe Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 110. Rest of Europe Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 111. Rest of Europe Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 112. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 113. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 114. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 115. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 116. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Value, By Country, 2020-2029, Million USD
TABLE 117. China Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 118. China Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 119. China Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 120. China Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 121. India Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 122. India Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 123. India Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 124. India Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 125. Japan Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 126. Japan Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 127. Japan Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 128. Japan Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 129. Australia Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 130. Australia Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 131. Australia Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 132. Australia Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 133. South Korea Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 134. South Korea Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 135. South Korea Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 136. South Korea Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 137. Rest of Asia Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 138. Rest of Asia Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 139. Rest of Asia Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 140. Rest of Asia Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 141. Rest of World Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 142. Rest of World Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 143. Rest of World Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 144. Rest of World Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 145. Rest of World Clinical Oncology Next Generation Sequencing Market Value, By Country, 2020-2029, Million USD
TABLE 146. Brazil Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 147. Brazil Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 148. Brazil Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 149. Brazil Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 150. South Africa Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 151. South Africa Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 152. South Africa Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 153. South Africa Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 154. GCC Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 155. GCC Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 156. GCC Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 157. GCC Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
TABLE 158. RoW Countries Clinical Oncology Next Generation Sequencing Market Value, By Workflow, 2020-2029, Million USD
TABLE 159. RoW Countries Clinical Oncology Next Generation Sequencing Market Value, By Technology, 2020-2029, Million USD
TABLE 160. RoW Countries Clinical Oncology Next Generation Sequencing Market Value, By Application, 2020-2029, Million USD
TABLE 161. RoW Countries Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD
RoW Countries Clinical Oncology Next Generation Sequencing Market Value, By End User, 2020-2029, Million USD

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us